Anixa Biosciences, Inc.
ANIX
$3.09
-$0.17-5.22%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.17M | 16.03M | 15.60M | 17.26M | 19.92M |
| Total Receivables | -- | -- | -- | -- | 173.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 713.00K | 1.42M | 1.17M | 1.43M | 1.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.89M | 17.45M | 16.77M | 18.69M | 21.36M |
|
|
|||||
| Total Current Assets | 15.89M | 17.45M | 16.77M | 18.69M | 21.36M |
| Net Property, Plant & Equipment | 193.00K | 202.00K | 211.00K | 220.00K | 229.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.08M | 17.65M | 16.98M | 18.91M | 21.59M |
|
|
|||||
| Total Accounts Payable | 165.00K | 276.00K | 284.00K | 600.00K | 525.00K |
| Total Accrued Expenses | 1.76M | 1.75M | 1.57M | 1.36M | 1.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.00K | 39.00K | 37.00K | 36.00K | 29.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.97M | 2.07M | 1.89M | 2.00M | 2.50M |
|
|
|||||
| Total Current Liabilities | 1.97M | 2.07M | 1.89M | 2.00M | 2.50M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 163.00K | 174.00K | 184.00K | 194.00K | 203.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.13M | 2.24M | 2.07M | 2.19M | 2.70M |
|
|
|||||
| Common Stock & APIC | 266.84M | 265.58M | 262.79M | 261.79M | 260.75M |
| Retained Earnings | -251.68M | -248.98M | -246.72M | -243.93M | -240.75M |
| Treasury Stock & Other | -- | -- | -- | -6.00K | -6.00K |
| Total Common Equity | 15.16M | 16.60M | 16.07M | 17.85M | 20.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.16M | 16.60M | 16.07M | 17.85M | 20.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.21M | -1.18M | -1.16M | -1.14M | -1.11M |
| Total Equity | 13.95M | 15.41M | 14.91M | 16.71M | 18.89M |
|
|
|||||